133 results match your criteria: "West Virginia University - Department of Medicine Section of Gastroenterology & Hepatology.[Affiliation]"
Clin Nutr ESPEN
December 2024
Section of Gastroenterology and Hepatology, Baylor College of Medicine Houston, Texas, USA. Electronic address:
Background: Helicobacter pylori (H. pylori) infection increases the risks of chronic gastritis, peptic ulcer diseases, and the incidence of gastric cancer. However, antibiotic resistance and adverse effects led to the emergence of alternative treatments such as probiotics supplementation.
View Article and Find Full Text PDFHepatol Commun
November 2024
Departamento de Gastroenterología, Escuela de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile.
Dig Dis Sci
October 2024
Division of Gastroenterology and Hepatology, School of Medicine, The University of Alabama at Birmingham, Birmingham, AL, 35205, USA.
JPGN Rep
August 2024
Department of Pediatrics, Division of Pediatric Gastroenterology and Hepatology West Virginia University School of Medicine Morgantown West Virginia USA.
Burkitt Lymphoma (BL) is an aggressive B-cell lymphoma predominantly encountered in pediatrics. Sporadic type typically involves the abdomen and/or pelvis. We present an 8-year-old Caucasian male with vomiting, weight loss, fatigue, and abdominal pain.
View Article and Find Full Text PDFLancet Reg Health West Pac
August 2024
Yong Loo Lin School of Medicine, National University Singapore, Singapore.
Hepatology
July 2024
Division of Gastroenterology, Department of Internal Medicine, Hepatology and Nutrition, Virginia Commonwealth University, Richmond, Virginia, USA.
Background And Aims: In a recent trial, patients with severe alcohol-associated hepatitis treated with anakinra plus zinc (A+Z) had lower survival and higher acute kidney injury (AKI) rates versus prednisone (PRED). We characterize the clinical factors and potential mechanisms associated with AKI development in that trial.
Approach And Results: Data from 147 participants in a multicenter randomized clinical trial (74 A+Z, 73 PRED) were analyzed.
Liver Transpl
November 2024
Center for Health Equity Research and Promotion, VA Pittsburgh Health Care System, Pittsburgh, Pennsylvania, USA.
Gastroenterology
June 2024
Department of Medicine, Case Western Reserve University, Cleveland, Ohio; Division of Gastroenterology, Veterans Affairs Northeast Ohio Healthcare System, Cleveland, Ohio.
Background & Aims: Barrett's esophagus (BE) is the precursor to esophageal adenocarcinoma (EAC). Endoscopic eradication therapy (EET) can be effective in eradicating BE and related neoplasia and has greater risk of harms and resource use than surveillance endoscopy. This clinical practice guideline aims to inform clinicians and patients by providing evidence-based practice recommendations for the use of EET in BE and related neoplasia.
View Article and Find Full Text PDFDig Dis Sci
June 2024
Center for Health Equity Research and Promotion, VA Pittsburgh Healthcare System, Pittsburgh, PA, USA.
Background: The Veterans Health Administration provides care to more than 100,000 Veterans with cirrhosis.
Aims: This implementation evaluation aimed to understand organizational resources and barriers associated with cirrhosis care.
Methods: Clinicians across 145 Department of Veterans Affairs (VA) medical centers (VAMCs) were surveyed in 2022 about implementing guideline-concordant cirrhosis care.
Hepatology
November 2024
Departamento de Gastroenterología, Escuela de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile.
Background And Aims: Alcohol-associated hepatitis (AH) poses significant short-term mortality. Existing prognostic models lack precision for 90-day mortality. Utilizing artificial intelligence in a global cohort, we sought to derive and validate an enhanced prognostic model.
View Article and Find Full Text PDFWorld J Gastrointest Endosc
March 2024
Section of Gastroenterology & Hepatology, West Virginia University School of Medicine, Morgantown, WV 26505, United States.
Hepatology
March 2024
Digestive Disease Research Center, Medical University of South Carolina, Charleston, South Carolina, USA.
Hepatology
January 2025
Digestive Disease Research Center, Medical University of South Carolina, Charleston, South Carolina, USA.
Hepatology
March 2024
Digestive Disease Research Center, Medical University of South Carolina, Charleston, South Carolina, USA.
Diabetologia
March 2024
Division of Gastroenterology and Hepatology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Aims/hypothesis: We aimed to determine whether the use of glucagon-like peptide-1 receptor agonists (GLP-1RA) in individuals with non-alcoholic fatty liver disease (NAFLD) and type 2 diabetes mellitus decreases the risk of new-onset adverse cardiovascular events (CVEs) and mortality rate compared with other glucose-lowering drugs in a real setting at a population level.
Methods: We conducted a population-based propensity-matched retrospective cohort study using TriNetX. The cohort comprised patients over 20 years old who were newly treated with glucose-lowering drugs between 1 January 2013 and 31 December 2021, and followed until 30 September 2022.
J Am Coll Cardiol
December 2023
Department of Health Metrics Sciences, Institute for Health Metrics and Evaluation, School of Medicine, University of Washington, Seattle, Washington, USA; Division of Cardiology, Department of Medicine, University of Washington, Seattle, Washington, USA. Electronic address:
Clin Gastroenterol Hepatol
April 2024
Department of Health Behavior and Policy, Virginia Commonwealth University, Richmond, Virginia.
Background & Aims: Patients with cirrhosis secondary to chronic hepatitis C virus (HCV) are at risk for hepatocellular carcinoma (HCC) despite a sustained virological response (SVR). We examined whether post-SVR liver stiffness measurement (LSM) could be used to stratify HCC risk.
Methods: This was a retrospective cohort study of 1850 participants identified from the Veterans Health Administration, with HCV cirrhosis and SVR, followed up over 5099 person-years, from the time of post-SVR elastography until death, HCC, or the end of the study.
Aliment Pharmacol Ther
January 2024
Research and Development, CymaBay Therapeutics, Inc, Newark, California, USA.
Curr Med Res Opin
October 2023
Gastroenterology and Hepatology Section, Baylor College of Medicine, Houston, TX, USA.
Objective: In the management of small and diminutive polyps, cold polypectomy is favored over electrocautery polypectomy. However, the optimal cold polypectomy technique is still controversial. Hence, this review aims to investigate the most effective cold technique for small and diminutive colorectal polyps.
View Article and Find Full Text PDFHepatol Commun
October 2023
Department of Medicine III, Gastroenterology, Metabolic Diseases and Intensive Care, University Hospital RWTH Aachen, Aachen, Germany.
Background: The hepatoprotective effects of aspirin have been observed in individuals with viral hepatitis; however, its impact on the general population remains uncertain. Understanding the association between aspirin use and the development of liver diseases is crucial for optimizing preventive strategies.
Methods: We identified individuals with aspirin use in the UK Biobank and the Penn Medicine Biobank, as well as propensity-score-matched controls.
Cancers (Basel)
August 2023
Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN 55905, USA.
Unlabelled: Metastatic colorectal cancer (mCRC) is a heterogeneous disease that can evoke discordant responses to therapy among different lesions in individual patients. The Response Evaluation Criteria in Solid Tumors (RECIST) criteria do not take into consideration response heterogeneity. We explored and developed lesion-based measurement response criteria to evaluate their prognostic effect on overall survival (OS).
View Article and Find Full Text PDFHepatology
April 2024
Division of Gastroenterology and Hepatology, Miami VA Medical System, Miami, Florida, USA.
Background And Aims: Although refractory hepatic hydrothorax (RH) is a serious complication of cirrhosis, waitlisted patients do not receive standardized Model for End-stage Liver Disease (MELD) exemption because of inadequate evidence suggesting mortality above biochemical MELD. This study aimed to examine liver-related death (LRD) associated with RH compared to refractory ascites (RA).
Approach And Results: This was a retrospective cohort study of Veterans with cirrhosis.
Hepatobiliary Surg Nutr
August 2023
Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.